Chronic pulmonary aspergillosis in a tertiary tuberculosis institute: A common entity missed commonly

Area of Science:

• Medical Mycology
• Pulmonology
• Infectious Diseases

Background:

• Chronic pulmonary aspergillosis (CPA) affects 3 million people globally, causing severe morbidity and mortality.
• CPA disproportionately affects individuals with mild immune suppression or chronic lung conditions.
• CPA presents diagnostic and therapeutic challenges, leading to persistent respiratory issues and reduced quality of life.

Purpose of the Study:

• To highlight the burden of CPA in patients with treated tuberculosis (TB).
• To review recent research and clinical guidelines for CPA diagnosis and management.
• To emphasize the need for heightened clinical suspicion, especially in TB-prevalent areas like India.

Main Methods:

• Review of existing literature on chronic pulmonary aspergillosis.
• Analysis of clinical guidelines and recent research findings.
• Focus on CPA presentation in the context of treated pulmonary tuberculosis.

Main Results:

• Treated pulmonary TB patients, especially those with cavities, are at increased risk for CPA.
• Diagnosis relies on a combination of symptoms, microbiological criteria, and suggestive radiological findings.
• Despite advances in mycology, understanding and timely diagnosis of CPA remain challenging.

Conclusions:

• CPA poses a significant health burden, particularly in populations with high TB prevalence.
• Integrated diagnostic approaches combining clinical, microbiological, and radiological data are essential.
• Further research and adherence to updated guidelines are necessary for optimal CPA management.